Chronic kidney disease (CKD) is abnormalities of kidney structure or function for more than 3 months.
Introduction
Chronic kidney disease (CKD) is abnormalities of kidney structure or function for more than 3 months. 1 About 10% of the world's population suffer from CKD, and every year there are millions of people die from its complications. 2 The results of Global Burden of Disease study in 2010 showed that CKD experienced an increase in the ranking of causes of death in the world, from 27 th to 18 th in 1990-2010. 3 As one of non-communicable diseases, CKD is a health problem that is still increasing in Indonesia. Based on Indonesia Basic Health Research (Riset Kesehatan Dasar) 2013, the prevalence of CKD increased along with increasing life expectancy with a peak at over 75 years of age. 4 Chronic kidney disease occurs when there is decreased glomerular filtration rate (GFR) for more than 3 months, namely GFR <60 mL/min/1.73m 2 which indicates CKD stage 3-5. 1 At those stages, the decreased GFR has caused various complications, one of which is hypovitaminosis D which includes vitamin D deficiency (25(OH)D <20 ng/mL) and vitamin D insufficiency (25(OH)D <30 ng/ml). [5] [6] [7] A decrease in GFR that occurs along with advancing stages of CKD may cause a decrease in vitamin D levels in patients with CKD through/ decreased 25(OH)D (25-hydroxyvitamin D/ calcidiol) supply into the kidney, increased fibroblast growth factor-23 (FGF-23) level, and reduced megalin receptor function inside proximal convoluted tubule (PCT).
and 15% experience vitamin D deficiency. 9 While in CKD, 70-80% patients experience vitamin D deficiency. 10 Hypovitaminosis D in CKD may increase CKD progression, as well as morbidity and mortality. 6, 11 Hypovitaminosis D may also cause mineral and bone disorder which leads to osteopenia and osteoporosis that may increase the risk of fracture. 12, 13 Therefore, mineral and bone disorder may cause disability and reduce the quality of life of patients with CKD. Kidney disease itself is a disease with the second largest funding from Healthcare and Social Security Agency (Badan Penyelenggara Jaminan Sosial Kesehatan, BPJS Kesehatan) after heart disease. 4 The mineral and bone disorder will certainly increase the burden of health costs in Indonesia.
Based on above explanation, it is important to know vitamin D levels difference among stages of CKD. This study aimed to determine the vitamin D levels difference among CKD stage 3, 4 and 5, and is expected to add information and data about vitamin D level in CKD so that it canprovide information to help determine cut-off point of vitamin D and proper vitamin D therapy in predialysis CKD.
Methods
This study was a cross-sectional study with comparative analysis conducted in AprilAugust 2018, and carried out using secondary data from previous studies taken from Dr 
Results
The number of subjects who met the criteria of this study was 100 subjects. Table 1 shows characteristics of study sample which grouped according to the stages of CKD. Most subjects with CKD stage 3, 4 and 5 were found to bemale. Subjects with CKD stage 4 were found to have the highest median age of 65 years, while subjects with CKD stage 3 had the lowest median age of 54 years. Most patients with CKD stage 3, 4 and 5 had over 50 years of age. There was a significant age difference among CKD stage 3, 4 and 5 (p=0.002) and there was a significant correlation between age and CKD stages (p=0.013). Table 2 Figure 2 shows a graph of the number of subjects based on hypovitaminosis D category in CKD stage 3, 4, and 5. In the graph, it was found that there was an increase in the number of subjects with vitamin D deficiency along with advancing stages of CKD. Table 3 shows the result of multiple linear regression test to control confounding variables. After multivariate test was performed to control confounding variables (BMI and age), the result showed that there was no significant difference in vitamin D levels among CKD stage 3, 4 and 5 (p=0.335 and p=0.736). The classical assumption test showed that there was no multicollinearity and error distribution had not followed normal distribution pattern. Transformation of the dependent variable was needed so that the error distribution followed the normal distribution pattern.
Discussion
Based on the results of the study, it was known that the general characteristics of the study subjects were predominantly male and most had an age above 50 years (Table 1) . These results are consistent with the results of research conducted by Diniz et al. 14 in Brazil involving 125 subjects with CKD who had an average age of 57.4 years and 55% of subjects were male. These results are also consistent with the results of research conducted by Rozita et al. 15 in Malaysia involving 50 subjects with CKD who had an average age of 53 years and 58% of the subjects were male. The result of this study also showed a correlation between age and CKD stages. CKD is more common in older age due to decreased renal function with increasing age and the presence of various risk factors for CKD such as diabetes and hypertension in older individuals. Based on the results of the study, there was no significant difference in vitamin D levels among CKD degrees 3, 4 and 5 (Table 3) , but the results showed that almost all (97%) study subjects had hypovitaminosis D (Table 2) . Hypovitaminosis D had occurred from CKD stage 3, and most subjects with CKD stage 3, 4, and 5 had vitamin D deficiency. These results are consistent with the research conducted by Rozita et al. 15 in Malaysia involving 50 subjects with CKD stage 2-4 and showed vitamin D deficiency was found in CKD stage 2, 3, and 4 with a mean 25(OH)D levels of 15.7 ng/mL, 16.5 ng/mL, and 15.5 ng/mL, respectively, and also there was no significant difference 14 in Brazil involving 125 subjects with CKD stage 2-5 and showed the majority of subjects had 25(OH)D levels below 30 ng/mL and also there was no significant difference in vitamin D levels among CKD stage 2-5. Similar results are also found in children with CKD. Study conducted by Lee et al. 17 in South Korea involving 113 children aged 1-18 years with CKD stage 2-5 showed that most subjects had 25(OH)D levels below 30 ng/mL.
Hypovitaminosis D is a common problem in the general population. The prevalence of vitamin D deficiency in South Asia is about 70% or higher, while the prevalence of vitamin D deficiency in Southeast Asia varies from 6-70%. 18 Hypovitaminosis D is also quite common in Indonesia characterized by 75.8% of healthy children aged 7-12 years old experience vitamin D insufficiency and 15% experience vitamin D deficiency.
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Hypovitaminosis D occurs in the general population in Indonesia even though Indonesia receives a lot of sunlight because it is located in the equatorial region. In addition, CKD can also cause decreased vitamin D level. 6 The occurrence of CKD will certainly cause a decrease in vitamin D levels in the community. This is evidenced by the results of research conducted by Rozita et al. 15 stating that in subjects with vitamin D deficiency, it was found that 25(OH)D levels were significantly lower in the group of subjects with CKD compared to the control group. Hypovitaminosis D in CKD may cause worsening renal function, increased CKD progression, and increased morbidity and mortality. This is because vitamin D has renoprotective effects that can reduce inflammation in the kidney, produce antifibrotic and antiapoptotic effects, prevent podocyte damage, and reduce intraglomerular pressure. 6, 11 Based on the results of the study, there was no significant difference in vitamin D levels among CKD stage 3, 4, and 5, but it was found that there was an increase in the number of subjects with vitamin D deficiency along with advancing stages of CKD and a decrease in the mean 25(OH)D levels along with advancing stages of CKD in the group of subjects with vitamin D insufficiency ( Table 2) . Increased stages of CKD indicate a decrease in GFR as a marker of renal filtration function.
1 A decrease in GFR may cause a decrease in vitamin D level. Decreased GFR may cause a decrease in supply of 25(OH)D to proximal convoluted tubule (PCT), an increase in fibroblast growth factor-23 (FGF-23) level in the body, and a decrease in megalin receptor function in PCT. Based on these mechanisms, it was hypothesized that there was a difference in vitamin D levels among CKD stages. The high prevalence of hypovitaminosis D in the general population in Indonesia may cause decreased vitamin D levels that occur in CKD patients does not show a significant difference. In addition, based on the results of the study, there was no decrease in vitamin D levels with advancing stages of CKD, whereas CKD stage 3 had the lowest median of vitamin D and CKD stage 4 had the highest median of vitamin D. This may be caused by factors not measured in this study that may affect vitamin D levels in this study, such as sun exposure, skin pigmentation, and the use of sunscreen. 19 Hypovitaminosis D may cause mineral and bone disorder in chronic kidney diseasemineral and bone disorder (CKD-MBD), decreased intestinal calcium absorption and renal calcium reabsorption which induce hypocalcemia. Hypocalcaemia may promote increased parathyroid hormone production which causes secondary hyperparathyroidism. 12 High bone turnover due to secondary hyperparathyroidism leads to high bone resorption (higher than bone formation) that induces hypercalcaemia, hyperphosphatemia, osteopenia and osteoporosis. 12, 13 Cardiovascular disease in form of vascular wall calcifications may occur due to hyperphosphatemia and hypercalcaemia. 5 Calcification and stiffness of blood vessels may cause increased systolic blood pressure and left ventricular hypertrophy. 13 The results of this study indicate that there was hypovitaminosis D starting from CKD stage 3 (Table 2 ). This study did not measure vitamin D levels in CKD stage 1 and 2 because at those stages, there are no signs and symptoms of CKD yet. 5 Research conducted by Diniz et al. 14 14, 20 These things can be achieved through several effects of vitamin D, namely reducing the renin-angiotensin system, increasing insulin secretion and sensitivity, preventing proliferation vascular smooth muscle cells proliferation, protecting normal endothelial cells function, controlling inflammatory processes, preventing myocardial cells proliferation and hypertrophy, and inhibiting anticoagulants activity. 20 Renoprotective activity of vitamin D may also reduce proteinuria and repair kidney damage by decreasing the renin-angiotensin system, decreasing activation of NF-κB (nuclear factorkappaB) transcription factors, inhibiting Wnt/β-Catenin pathway, and maintaining the integrity of slit diaphragm and protecting glomerular filtration membrane.
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The limitation of this study is that the factors that can affect vitamin D levels in patients with CKD were not measured. These factors include factors that can affect vitamin D production in the skin such as sun exposure (can be measured through daily activities or types of clothing that are often used), skin pigmentation/race and sunscreen use. Therefore, hypovitaminosis D in the subjects of this study was not solely caused by decreased GFR alone, but there were various other influential factors (confounding factors) that were not measured in this study. Substantially based on theory and literature, there is difference in vitamin D levels among CKD stage 3, 4, and 5, but statistically this study showed a conclusion that is not significant to the hypothesis made.
Based on the results of the study it can be concluded that there is no difference in vitamin D levels among CKD stage 3, 4, and 5, but hypovitaminosis D can be found since CKD stage 3 to 5 so that examination of vitamin D level and vitamin D supplementation are important things to do. Various limitations found in this study cause the results of the study could not significantly detect difference in vitamin D levels among stages of CKD. Thus, further research is needed by paying attention to and taking into account other factors that can affect vitamin D levels in patients with CKD.
